-
Non Regulatory July 22, 2022 EnglishFinalization of share buyback program in Initiator Pharma
-
Regulatory July 18, 2022 EnglishLast day of trading in BTA in Initiator Pharma
Share
Initiator Pharma Numbers
-
Number of men affected by Erectile Dysfunction worldwide 150 million
-
Number of people worldwide that are diagnosed with Trigeminal Neuralgia every year: 15000
-
Men with Erectile Dysfunction who do not respond to drug therapy 40 %

Initiator Pharma currently has a portfolio of four projects, of which two are in clinical development and two are in preclinical development.

CEO letter
With a plan for secured financing, an attractive portfolio of clinical assets progressing according to plan, and our latest management team member Christina Guldberg onboard as Senior Director, Clinical Development and Outcomes Research (Rare Diseases), a new position designed to strengthen our clinical development and Orphan drug capabilities, I see the future with confidence and look forward to keep you updated on our progress.
